Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The base region of the Ebolavirus glycoprotein (GP1 subunit) is a critical structural element that stabilizes the prefusion conformation of the GP trimer. Located at the membrane-proximal end of the GP, it clamps the internal fusion loop and an α-helix from the adjacent GP2 subunit, maintaining the GP in a metastable state. This region is also a target for neutralizing antibodies like KZ52, which can disrupt viral entry.
Neutralizing antibodies (e.g., KZ52) block conformational changes required for membrane fusion or prevent proper assembly/stability of functional trimers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ebolavirus Glycoprotein Base Region (GP Base Region).